PCR76 Generating Health-State Utility Values in Patients Treated with Second-Line Systemic Therapy for Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL)
Abstract
Authors
I.A. Soare M. Little S.L. Klijn A. Elsada A. Gibson F.F. Liu F. Becker